Competition seen intensified for proton pump inhibitors market

Published: 2009-11-18 06:57:00

Updated: 2009-11-18 06:57:00

As Ilyang Pharm is poised to join the PPI market by launching newly developed antiulcerant agent Noltec (ilaprazole) within this year, marketers may need to come up with more distinguished strategies, said an industry watcher.

Local pharmaceutical companies are stepping up their marketing in t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK